Article Details

Amphivena Reports Data on Phase 1 Study of AMV564 at Ash Annual Meeting

Retrieved on: 2019-12-09 06:41:15

Tags for this article:

Click the tags to see associated articles and topics

Amphivena Reports Data on Phase 1 Study of AMV564 at Ash Annual Meeting. View article details on hiswai:

Excerpt

<div>Amphivena has raised $88.5 M to date in Series A, B and C venture financings led by NanoDimension, <b>Qiming Venture Partners</b> USA, MPM Capital ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up